国产精品区一 I 欧美xxxx做受视频 I 亚洲中文字幕人成乱码 I 小早川怜子xxxxaⅴ在线 I 亚洲一区欧美激情 I 黄色免费观看网址 I 91成人小视频 I 日韩在线视频观看 I 强迫大乳人妻中文字幕 I 桃花久久 I 久久天天躁夜夜躁狠狠躁 I 精品人妻伦一二三区久久aaa片 I 日韩亚洲欧美视频 I 欧美国产精品久久久 I 亚洲女人天堂 I 亚洲免费性 I 在线观看国产精品普通话对白精品 I av大秀 I 91av综合 I 两个人看的www视频免费完整版 I 51自拍视频 I 911亚洲精品第一 I 日本美女毛片 I 午夜亚洲福利在线老司机 I 亚洲精品成人av I 亚洲精品无码久久久久av麻豆 I 欧美一级片网站 I 特黄熟妇丰满人妻无码 I 黄色片xxx I 日本熟妇xxxx潮喷视频

Another good news! One more clinical trial application accepted
On the evening of August 1, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as "the Company" or "Kexing Biopharm") announced that it had just received the Notice of Acceptance, an administrative license document issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), indicating that its clinical trial application for "Pegylated Human Granulocyte Colony-stimulating Factor Injection" was accepted.

Main Contents of Notice of Acceptance
1. Product Name: Pegylated Human Granulocyte Colony-stimulating Factor Injection
2. Application Item: clinical trial for registration of drugs produced in China
3. Acceptance No.: CXSL2200346G
4. Indications: This product is intended for patients with non-bone marrow cancer to reduce the incidence of infections manifested as febrile neutropenia when treated with myelosuppressive anticancer drugs that are prone to cause clinically significant febrile neutropenia.
5. Dosage Form: injection

The promotion of the R&D of Pegylated Human Granulocyte Colony-stimulating Factor Injection will help the Company further optimize the product portfolio, enrich the product pipelines, enhance the overall R&D capability, and build up the long-term profitability.

Pegylated Human Granulocyte Colony-stimulating Factor Injection

The Pegylated Human Granulocyte Colony-stimulating Factor Injection is a long-acting human granulocyte colony- stimulating factor (G-CSF) preparation, obtained by the conjugation of polyethylene glycol with G-CSF produced by gene recombination technology. It is a biosimilar to the innovator product Neulasta?, with its molecular structure, formula, strength and indications consistent with those of the latter.
Compared to human granulocyte colony-stimulating factor injection, Pegylated Human Granulocyte Colony-stimulating Factor Injection prolongs the half-life, so as to reduce the frequency of administrations and improve the medication compliance.